Program

As a unique program, Prof. Szász will hold a Fractal physiology course before the conference. This is the first time that this topic will be presented in Greece.

Place: Lab of Physiology, Medical School, Aristotle University of Thessaloniki http://physiology.med.auth.gr/content/dorothea-kapoukranidou-biographical-note

The outline of the talk is the following:

  •  Challenge of complexity
  • Self-organized networking
  • Structural complexity
  • Dynamical complexity
  •  Loss of complexity
  • Perspectives

The talk is optional and there will be no attendance fee.

The organizers warmly welcome everybody.

Conference of International Clinical Hyperthermia Society
19-21. September 2019, Thessaloniki
Place of the conference:
Hotel Panorama ****
Under the Auspices of Mayor and Municipality of Panorama

 

  1. Day – September 19, 2019

Starts        Ends

9:00         13:00       Fractal Physiology Course: Complexity in Medicine.

Venue: Aristotelian Univ-Thessaloniki, dept of Physiology (optional, free of charge)

 

14:00       19:00       Registration (ongoing)

 

15:00       16:00       Opening

 

  • Welcome notes
  • Opening remarks by Chairman Aias-Theodoros Papastavrou
  • Minister Kostas Gioulekas, President of Permanent Committee of Foreign Affairs and Defence of Hellenic Parliament
  • Ignatios Kaitezidis Mayor of Panorama, Pylea, Hortiati,
  • Athanasios Exadaktilos, President Hellenic Med. Association
  • Nikos Nitsas, Pres. Med. Association Thessaloniki, Other Dignitaries
  • Mr. Konstantinos Zervas, Mayor of Thessaloniki
  • Andras Szasz, Hon. president ICHS

 

Session I.

Chair: Papastavrou TA

 

16:00       16:10       Oncological hyperthermia in Greece

(Uzunoglou N)

16:15       16:45       Achievements and challenges in oncological hyperthermia

(Datta NR)

16:45       17:05       The role of Oncothermia in Integrative Oncology

 (Barich AJ)

 

17:05       18:00       Cocktail Reception

 

18:00      19:00      Board Meeting

 

  1. Day – September 20, 2019

 

Session II.

 Chair: Herzog A

 

9:00         9:30        Strengthening evidence for the acceptance of clinical

thermoradiotherapy in the oncology community

(Bodis S)

 

9:30         9:50        Modulated electro-hyperthermia, an effective oncological

treatment and chemosensitizer

(Arrojo E)

 

9:50         10:10       Clinical Case Report mEHT – Results on CA

Esterioneuroblastoma – Brazilian Experience

(Pontes S)

 

10:10       10:30       Multimodal immunotherapy for patients with ovarian

cancer

(Van Gool S)

 

10:30       10:50       Modulated electro-hyperthermia, a local treatment with

systemic effect

(Arrojo E)

 

10:50       11:20      Coffee break

(The poster # 6  “Increasing the quality of life with hyperthermia in oncological patients” (Badzgaradze, Sophie – Medical center ‘’SAROV’’) will be presented during the coffee break 10:50 – 11:20 on September 20, because of authors pending departure.)

 

                            Session   III.

                              Chair: Arrojo E

                               

11:20       11:40       Modulated electro-hyperthermia as Palliative treatment for

Pancreatic cancer:  a retrospective observational study on

106 patients

(Fiorentini G)

 

11:40       12:00       Effectiveness of Hyperthermia in Clinical Stage Ⅳ

Pancreatic Cancer

(Ono E)

 

12:00       12:20       Final Results on Local Control in Cervical Cancer Patients

treated with Chemoradiotherapy with/without Modulated

Electro-Hyperthermia as Published in PLoS ONE (2019) (Minnaar CA)

 

12:20       12:40       Hyperthermia as part of multimodal immunotherapy for

patients with GBM

(Van Gool S)

 

12:40       13:50       Lunch

Session IV.

Chair: Minnaar CA

 

13:50       14:10       Modulated electro-hyperthermia for the treatment of

Relapsed Brain Tumors

(Fiorentini G)

 

14:10       14:30       Modulated electro-hyperthermia in metastatic colorectal

cancer: a retrospective cohort study with meta-comparison (Roussakow S)

 

14:30       14:50       How to set up an individual program of hyperthermia and conventional treatment in heavily pretreated cancer    patients

(Herzog A)

 

14:50       15:10       Potential application of neoadjuvant chemotherapy plus

modulated electro-hyperthermia (mEHT, trade

name: Oncothermia) among patients with advanced

cancer: retrospective clinical analysis of single hospital

experiences

(Kim JH)

 

15:10       15:40       Coffee break

Session V.

Chair: Fiorentini G

 

15:40       16:00       Modulated electro-hyperthermia in uncommon/aggressive

cancers. A safe and promising treatment

(Arrojo E)

 

16:00       16:20       Hyperthermia for the management of cervical cancer: a

review of techniques, protocols and outcomes

(Minnaar CA)

 

16:20       16:40       Survival time in cancer patients getting in addition to conventional treatments hyperthermia and complementary treatments in comparison to published data of similar patients. Retrospective study over a period of 12 years. Project of a doctorate thesis

(Herzog A)

 

Session VI.

Chair: Krenacs T

 

16:40       17:00       Efficacy and dose of local hyperthermia

(Szasz O)

 

17:00       17:20       Effects of modulated electro-hyperthermia on

peripheral white blood cell counts of clinically

responding and non-responding patients

(Szasz M)

 

17:20       17:40       Effects of modulated electro-hyperthermia on triple

negative mouse breast cancer with differential metastatic potential

(Schvarcz Cs)

 

17:40       18:00       Modulated electro-hyperthermia suppresses H19, a

tumor promoting long non coding RNA, in a triple-negative breast cancer model

(Danics L)

 

Chair: Daniilidis L

18:00 – 18:20     “Nanoparticles in combination with Radiotherapy and Hyperthermia in the treatment of Head & Neck Cancer. A critical appraisal”

(Kouloulias V.)

19:30       20:30       Thessaloniki tour 

 

20:30       23:30      Gala dinner

 

  1. Day – September 21, 2019

 

VII. Session

Chair: Samaras T

 

9:30         9:50         Differential tumor damage by modulated

electro-hyperthermia (mEHT)

(Krenacs T)

 

9:50         10:10       Effects of modulated electro-hyperthermia on peripheral

white blood cell counts — a pilot study

(Karaszi A)

 

10:10       10:30       Modulated electro-hyperthermia effectiveness compared

with classic chemotherapy and radiotherapy on a pancreas adenocarcinoma cell line

(Forika G)

 

10:30       10:50       Modulated electro-hyperthermia and combined primary,

immortalized NK-cell therapy in human A2058 xenograft model

(Vancsik T)

 

10:50       11:20       Coffee break with poster session

 

VIII. Session

Chair: Szasz M

 

11:20       11:40       Thomas-Treatment protocol for studying the effect of

modulated electro-hyperthermia on melanoma lung metastasis in a mouse model

(Thomas MJ)

 

11:40       12:00       Evaluation of clinical studies when no reference arm exists

(Szasz A)

 

12:00       12:20       Computational study of simplified numerical phantoms

inside capacitive hyperthermia devices

(Alexiou G)

 

12:20       13:20       Lunch

 

 IX. Session

Chair: Szasz A

 

13:20       13:40       Exploiting autoimmunity unleashed by an off-label low-

dose immune checkpoint blockade to treat advanced cancer

(Bakacs T)

 

13:40       14:00       Electro-Hyperthermia and Immunotherapy Combinations

for the Treatment of Cancer

(Wang YS)

 

14:00       14:20       Numerical Simulation and Evaluation of Magnetic Particle

Hyperthermia System and Conditions

(Maniotis N)

 

14:20       14:40       The Effects of microwave normothermic irradiation on

cultured cancer cells

(Asano M)

 

15:00       15:30       Coffee break with poster session

 

X. Session

Chair: Szasz O

 

15:30       15:50       Examination of the optimum anticancer agent with a

thermal effect for non-small cell lung cancer

(Masato S)

 

15:50       16:10       Combined magnetic hyperthermia and magnetomechanical

treatment on breast cancer and non-cancerous cells

(Tsiapla AR)

XI. Session

Chair: Barich AJ

 

16:10 – 16:30      “Computational study of simplified numerical phantoms inside capacitive hyperthermia devices”

 (Samaras TH)

16:50 – 17:20     Adjournment and closing Remarks

 (Samaras TH)

17:20 – 17:30     Awards

 (Szasz O and Acs B)

17:30 – 19:30    Visit to KEDEK: Presentation of ongoing multi-disciplinary research

Programs at the Aristotelian University (The bus will leave from the front of hotel)

 

  1. Day – September 22, 2019

 

9:30         12:45      Half day tour of Vergina

 

13:00      14:45      Lunch

 

14:45      15:30      Arrival SKG Airport

 Poster presentation

Poster session will be on 21 September, during the coffee breaks

The poster # 6  “Increasing the quality of life with hyperthermia in oncological patients” (Badzgaradze, Sophie – Medical center ‘’SAROV’’) will be presented during the coffee break 10:50 – 11:20 on September 20, because of authors pending departure.

 

  1. Combined magnetic hyperthermia and magneto mechanical treatment on breast cancer and non-cancerous cells (Tsiapla, Aikaterini-Rafailia, Department of Physics, Aristotle University of Thessaloniki)
  2. Reduction of magnetic fluid hyperthermia side effects in phantom models and ex vivo tissues using intermittent Alternating Magnetic Field (Kalimeri Antonia Areti- Department of Physics, Aristotle University of Thessaloniki)
  3. Malignant retroperitoneal HISTIOSARCOMA and ONCOTHERMIA (Marangos, Michael- 424 General Military Hospital of Thessaloniki)
  4. Oncothermia for lung cancer with brain metastases and extended hypermetabolic lymphadenopathy (PET CT) (Marangos, Michael- 424 General Military Hospital of Thessaloniki)
  5. Palliative oncothermia in patient with metastatic breast cancer and significant comorbidities. our experience in thessaloniki oncothermia center (Marangos, Michael- 424 General Military Hospital of Thessaloniki)
  6. Increasing the quality of life with hyperthermia in oncological patients (Badzgaradze, Sophie- Medical center “SAROV”)
  7. iTRAQ-based proteomics analysis reveals the differentially expressed proteins related to radiosensitivity induced by hyperthermia in highly invasive human non-small cell lung cancer cells (Zhang Shiron- 1Department of Translational Medicine Centre, Hangzhou First People’s Hospital, Zhejiang Medical University, Hangzhou, China)
  8. Microwave hyperthermia increases sensitivity to radiation in highly invasive human non-small cell lung cancer cells (Zhao Yanyan- 1Department of Translational Medicine Centre, Hangzhou First People’s Hospital, Zhejiang Medical University, Hangzhou, China)

You can download the abstract booklet from here: Abstract booklet

 

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close